Article tools
Author information

Research Article

Interaction between glucose and free fatty acid metabolism in human skeletal muscle.

D E Kelley, M Mokan, J A Simoneau and L J Mandarino

Department of Medicine, University of Pittsburgh, Pennsylvania 15213.

The mechanism by which FFA metabolism inhibits intracellular insulin-mediated muscle glucose metabolism in normal humans is unknown. We used the leg balance technique with muscle biopsies to determine how experimental maintenance of FFA during hyperinsulinemia alters muscle glucose uptake, oxidation, glycolysis, storage, pyruvate dehydrogenase (PDH), or glycogen synthase (GS). 10 healthy volunteers had two euglycemic insulin clamp experiments. On one occasion, FFA were maintained by lipid emulsion infusion; on the other, FFA were allowed to fall. Leg FFA uptake was monitored with [9,10-3H]-palmitate. Maintenance of FFA during hyperinsulinemia decreased muscle glucose uptake (1.57 +/- 0.31 vs 2.44 +/- 0.39 mumol/min per 100 ml tissue, P < 0.01), leg respiratory quotient (0.86 +/- 0.02 vs 0.93 +/- 0.02, P < 0.05), contribution of glucose to leg oxygen consumption (53 +/- 6 vs 76 +/- 8%, P < 0.05), and PDH activity (0.328 +/- 0.053 vs 0.662 +/- 0.176 nmol/min per mg, P < 0.05). Leg lactate balance was increased. The greatest effect of FFA replacement was reduced muscle glucose storage (0.36 +/- 0.20 vs 1.24 +/- 0.25 mumol/min per 100 ml, P < 0.01), accompanied by decreased GS fractional velocity (0.129 +/- 0.26 vs 0.169 +/- 0.033, P < 0.01). These results confirm in human skeletal muscle the existence of competition between glucose and FFA as oxidative fuels, mediated by suppression of PDH. Maintenance of FFA levels during hyperinsulinemia most strikingly inhibited leg muscle glucose storage, accompanied by decreased GS activity.

Browse pages

Click on an image below to see the page. View PDF of the complete article


Articles that cite this article:

Splanchnic lipolysis in human obesity
Soren Nielsen, ZengKui Guo, C. Michael Johnson, Donald D. Hensrud, Michael D. Jensen
J Clin Invest 113(11):1582. doi:10.1172/JCI21047 [CrossRef]

Prevention of fat-induced insulin resistance by salicylate
Jason K. Kim, Yoon-Jung Kim, Jonathan J. Fillmore, Yan Chen, Irene Moore, Jongsoon Lee, Minsheng Yuan, Zhi Wei Li, Michael Karin, Pascale Perret
J Clin Invest 108(3):437. doi:10.1172/JCI11559 [CrossRef]

Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor
Barbara Ukropcova, Michele Mcneil, Olga Sereda, Lilian De jonge, Hui Xie, George A. Bray, Steven R. Smith
J Clin Invest 115(7):1934. doi:10.1172/JCI24332 [CrossRef]

The effect of starvation on leucine, alanine and glucose metabolism in obese subjects
A. M. Umpleby, I. N. Scobie, M. A. Boroujerdi, P. H. SÖnksen
Eur J Clin Invest 25(8):619. doi:10.1111/j.1365-2362.1995.tb01755.x [CrossRef]

Key metabolite kinetics in human skeletal muscle during ischaemia and reperfusion: measurement by microdialysis
M. MÜller, R. Schmid, M. Nieszpaur-los, A. Fassolt, P. LÖnnroth, P. Fasching, H. G. Eichler
Eur J Clin Invest 25(8):601. doi:10.1111/j.1365-2362.1995.tb01752.x [CrossRef]

Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
Adilson Guilherme, Joseph V. Virbasius, Vishwajeet Puri, Michael P. Czech
Nat Rev Mol Cell Biol 9(5):367. doi:10.1038/nrm2391 [CrossRef]

Is Visceral Fat Involved in the Pathogenesis of the Metabolic Syndrome? Human Model
Michael D. Jensen
Obes Res 14(2s):20S. doi:10.1038/oby.2006.278 [CrossRef]